Yüklüyor......
Low-molecular-weight polymer–drug conjugates for synergistic anticancer activity of camptothecin and doxorubicin combinations
BACKGROUND: High-molecular-weight (MW) polymers (>50,000 Da) can be conjugated to chemotherapy drugs in order to improve their tumor accumulation, while low MW polymers ≤10,000 Da are often overlooked due to faster plasma clearance. Small polymers, however, may facilitate deeper tumor penetration...
Kaydedildi:
| Yayımlandı: | Nanomedicine (Lond) |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Future Medicine Ltd
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4910946/ https://ncbi.nlm.nih.gov/pubmed/27079141 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/nnm.16.33 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|